ABSTRACr Eight patients with exercise-induced asthma participated in a single-blind trial comparing the protective effects of inhaled lignocaine (estimated dose 48 mg), sodium cromoglycate (estimated dose 12 mg), and ipratropium bromide (estimated dose 120 ,g ipratropium bromide were 38 1% (5-0), 34.5% (6-1), 11-3% (3-7), and 19-3% (7-4) respectively. Similarly, the mean maximal falls in MMFR after saline, lignocaine, sodium cromoglycate, and ipratropium bromide were 54 4% (5-2), 52 9% (7 7), 23-6% (6-6), and 32-1% (10(5) cholinergic receptors in the airways. In this study we have compared the effect of inhaled lignocaine, ipratropium bromide, and sodium cromoglycate in eight patients with extrinsic and reproducible exercise-induced asthma.
Patients and methodsTwelve patients with extrinsic and reproducible exercise-induced asthma were included in the trial. Four of these patients had to be excluded because they developed considerable and prolonged bronchoconstriction after inhalation of lignocaine (4 g/l). The remaining eight patients, aged 17-49 years (mean 312, SEM 4(0) were studied. Sodium cromoglycate and bronchodilator drugs were discontinued for 24 hours before each test was carried out (patients taking oral or aerosol corticosteroids or antihistamines had been excluded from the study). All the patients were non-smokers and gave informed consent to be studied. Forced expiratory volume in one second (FEV,) and maximum mid-expiratory flow rates (MMFR) were measured on a water-737 on 13 May 2018 by guest. Protected by copyright.